{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T15:08:16Z","timestamp":1721315296877},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,7,1]]},"DOI":"10.1038\/sj.gt.3301481","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T18:59:08Z","timestamp":1032375548000},"page":"1033-1042","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters"],"prefix":"10.1038","volume":"8","author":[{"given":"GC","family":"Jayan","sequence":"first","affiliation":[]},{"given":"P","family":"Cordelier","sequence":"additional","affiliation":[]},{"given":"C","family":"Patel","sequence":"additional","affiliation":[]},{"given":"M","family":"BouHamdan","sequence":"additional","affiliation":[]},{"given":"R Paul","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"J","family":"Lisziewicz","sequence":"additional","affiliation":[]},{"given":"RJ","family":"Pomerantz","sequence":"additional","affiliation":[]},{"given":"DS","family":"Strayer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2001,7,6]]},"reference":[{"key":"BF3301481_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.gt.3300368","volume":"4","author":"DS Strayer","year":"1997","unstructured":"Strayer DS, Kondo R, Milano J, Duan LX . Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells Gene Therapy 1997 4: 219\u2013225","journal-title":"Gene Therapy"},{"key":"BF3301481_CR2","doi-asserted-by":"crossref","first-page":"24741","DOI":"10.1016\/S0021-9258(18)40066-X","volume":"271","author":"DS Strayer","year":"1996","unstructured":"Strayer DS . SV40 as an effective gene transfer vector in vitro J Biol Chem 1996 271: 24741\u201324746","journal-title":"J Biol Chem"},{"key":"BF3301481_CR3","doi-asserted-by":"publisher","first-page":"8000","DOI":"10.1073\/pnas.90.17.8000","volume":"90","author":"J Lisziewicz","year":"1993","unstructured":"Lisziewicz J et al. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS Proc Natl Acad Sci USA 1993 90: 8000\u20138004","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301481_CR4","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1073\/pnas.88.9.4045","volume":"88","author":"MB Feinberg","year":"1991","unstructured":"Feinberg MB, Baltimore D, Frankel AD . The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation Proc Natl Acad Sci USA 1991 88: 4045\u20134049","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301481_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/jvi.69.1.206-212.1995","volume":"69","author":"J Lisziewicz","year":"1995","unstructured":"Lisziewicz J et al. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy J Virol 1995 69: 206\u2013212","journal-title":"J Virol"},{"key":"BF3301481_CR6","first-page":"218","volume":"2","author":"J Lisziewicz","year":"1995","unstructured":"Lisziewicz J, Sun D, Lisziewicz A, Gallo RC . Antitat gene therapy: a candidate for late-stage AIDS patients Gene Therapy 1995 2: 218\u2013222","journal-title":"Gene Therapy"},{"key":"BF3301481_CR7","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1126\/science.280.5371.1880","volume":"280","author":"M Emerman","year":"1998","unstructured":"Emerman M, Malim MH . HIV-1 regulatory\/accessory genes: keys to unraveling viral and host cell biology Science 1998 280: 1880\u20131884","journal-title":"Science"},{"key":"BF3301481_CR8","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1093\/nar\/20.18.4903","volume":"20","author":"RS Goomer","year":"1992","unstructured":"Goomer RS, Kunkel GR . The transcriptional start site for a human U6 small nuclear RNA gene is dictated by a compound promoter element consisting of the PSE and the TATA box Nucleic Acids Res 1992 20: 4903\u20134912","journal-title":"Nucleic Acids Res"},{"key":"BF3301481_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1101\/gad.2.2.196","volume":"2","author":"GR Kunkel","year":"1988","unstructured":"Kunkel GR, Pederson T . Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used Genes Dev 1988 2: 196\u2013204","journal-title":"Genes Dev"},{"key":"BF3301481_CR10","first-page":"75","volume":"3","author":"E Bertrand","year":"1997","unstructured":"Bertrand E et al. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization RNA 1997 3: 75\u201388","journal-title":"RNA"},{"key":"BF3301481_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/sj.gt.3300354","volume":"4","author":"PD Good","year":"1997","unstructured":"Good PD et al. Expression of small, therapeutic RNAs in human cell nuclei Gene Therapy 1997 4: 45\u201354","journal-title":"Gene Therapy"},{"key":"BF3301481_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0092-8674(90)90455-N","volume":"63","author":"BA Sullenger","year":"1990","unstructured":"Sullenger BA, Gallardo HF, Ungers GE, Gilboa E . Overexpression of TAR sequence renders cells resistant to human immunodeficiency virus replication Cell 1990 63: 601\u2013608","journal-title":"Cell"},{"key":"BF3301481_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/334440a0","volume":"334","author":"MS Saag","year":"1988","unstructured":"Saag MS et al. Extensive variation of human immunodeficiency virus type-1 in vivo Nature 1988 334: 440\u2013444","journal-title":"Nature"},{"key":"BF3301481_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sj.gt.3300864","volume":"6","author":"M BouHamdan","year":"1999","unstructured":"BouHamdan M, Duan LX, Pomerantz RJ, Strayer DS . Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection Gene Therapy 1999 6: 660\u2013666","journal-title":"Gene Therapy"},{"key":"BF3301481_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1385\/1-59259-215-5:61","volume-title":"Methods in Molecular Biology: Gene Targeting Vector Protocols 133","author":"DS Strayer","year":"1999","unstructured":"Strayer DS . Effective gene transfer using viral vectors based on SV40. In: Kmiec EB (ed.) Methods in Molecular Biology: Gene Targeting Vector Protocols 133 Humana Press: New York 1999 61\u201374"},{"key":"BF3301481_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory AH, Owens TC, Barltrop JA, Cory JG . Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture Cancer Commun 1991 3: 207","journal-title":"Cancer Commun"},{"key":"BF3301481_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/sj.gt.3300623","volume":"5","author":"R Kondo","year":"1998","unstructured":"Kondo R, Feitelson MA, Strayer DS . Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent Gene Therapy 1998 5: 575\u2013582","journal-title":"Gene Therapy"},{"key":"BF3301481_CR18","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/sj.gt.3301159","volume":"7","author":"DS Strayer","year":"2000","unstructured":"Strayer DS et al. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors Gene Therapy 2000 7: 886\u2013895","journal-title":"Gene Therapy"},{"key":"BF3301481_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1053\/gast.2000.19577","volume":"119","author":"BV Sauter","year":"2000","unstructured":"Sauter BV et al. Gene transfer to the liver using a replication-deficient recombinant SV40 vector results in long-term amelioration of jaundice in Gunn rats Gastroenterology 2000 119: 1348\u20131357","journal-title":"Gastroenterology"},{"key":"BF3301481_CR20","first-page":"570","volume":"2","author":"DS Strayer","year":"2000","unstructured":"Strayer DS . SV40-based gene transfer vectors: turning an adversary into a friend Curr Opin Mol Therapeut 2000 2: 570\u2013578","journal-title":"Curr Opin Mol Therapeut"},{"key":"BF3301481_CR21","first-page":"82","volume":"3","author":"J Lisziewicz","year":"1991","unstructured":"Lisziewicz J, Rappaport J, Dhar R . Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression New Biol 1991 3: 82\u201389","journal-title":"New Biol"},{"key":"BF3301481_CR22","first-page":"208","volume":"1","author":"HK Chang","year":"1994","unstructured":"Chang HK et al. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1 Gene Therapy 1994 1: 208\u2013216","journal-title":"Gene Therapy"},{"key":"BF3301481_CR23","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1126\/science.1359646","volume":"258","author":"S Chatterjee","year":"1992","unstructured":"Chatterjee S, Johnson PR, Wong KK Jr . Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector Science 1992 258: 1485\u20131488","journal-title":"Science"},{"key":"BF3301481_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/jvi.67.1.239-248.1993","volume":"67","author":"YS Kim","year":"1993","unstructured":"Kim YS, Risser R . TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat protein J Virol 1993 67: 239\u2013248","journal-title":"J Virol"},{"key":"BF3301481_CR25","first-page":"269","volume":"2","author":"D Robinson","year":"1995","unstructured":"Robinson D, Elliott JF, Chang LJ . Retroviral vector with a CMV-IE\/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat Gene Therapy 1995 2: 269\u2013278","journal-title":"Gene Therapy"},{"key":"BF3301481_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1089\/hum.1998.9.5-649","volume":"9","author":"D Rund","year":"1998","unstructured":"Rund D et al. Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV 40 pseudovirion Hum Gene Ther 1998 9: 649\u2013657","journal-title":"Hum Gene Ther"},{"key":"BF3301481_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.gt.3300793","volume":"6","author":"M Zern","year":"1999","unstructured":"Zern M et al. A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line Gene Therapy 1999 6: 114\u2013120","journal-title":"Gene Therapy"},{"key":"BF3301481_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<375::AID-JCP1>3.0.CO;2-8","volume":"181","author":"DS Strayer","year":"1999","unstructured":"Strayer DS . Gene therapy using SV40-derived vectors: what does the future hold? J Cell Physiol 1999 181: 375\u2013384","journal-title":"J Cell Physiol"},{"key":"BF3301481_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0952-7915(97)80052-0","volume":"9","author":"C Yee","year":"1997","unstructured":"Yee C, Riddell SR, Greenberg PD . Prospects for adoptive T cell therapy Curr Opin Immunol 1997 9: 702\u2013708","journal-title":"Curr Opin Immunol"},{"key":"BF3301481_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1126\/science.285.5427.546","volume":"285","author":"PD Greenberg","year":"1999","unstructured":"Greenberg PD, Riddell SR . Deficient cellular immunity-finding and fixing the defects Science 1999 285: 546\u2013551","journal-title":"Science"},{"key":"BF3301481_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1055\/s-2007-1007099","volume":"19","author":"DS Strayer","year":"1999","unstructured":"Strayer DS, Zern MA . Gene delivery to the liver using SV40-derived vectors Semin Liver Dis 1999 19: 71\u201381","journal-title":"Semin Liver Dis"},{"key":"BF3301481_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0166-0934(81)90051-3","volume":"3","author":"BH Rosenberg","year":"1981","unstructured":"Rosenberg BH, Deutsch JF, Ungers GE . Growth and purification of SV40 virus for biochemical studies J Virol Meth 1981 3: 167\u2013176","journal-title":"J Virol Meth"},{"key":"BF3301481_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2144\/97223bm16","volume":"22","author":"DS Strayer","year":"1997","unstructured":"Strayer DS et al. Titering replication-defective virus for use in gene transfer BioTechniques 1997 22: 447\u2013450","journal-title":"BioTechniques"},{"key":"BF3301481_CR34","volume-title":"Molecular Cloning: A Laboratory Manual","author":"T Maniatis","year":"1982","unstructured":"Maniatis T . Molecular Cloning: A Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor 1982"},{"key":"BF3301481_CR35","unstructured":"CellTiter 96 Non-Radioactive Cell Proliferation Assay Technical Bulletin, TB112, Promega Corporation"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301481","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:09:24Z","timestamp":1648602564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,1]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2001,7,1]]}},"alternative-id":["BF3301481"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301481","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7,1]]},"assertion":[{"value":"16 January 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}